Work

Supplementary Data from Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure S4. MDA-7/IL-24 engineering confers T cells with improved therapeutic activity in eradication of prostate cancer.

DOI: 10.1158/0008-5472.22430427

Authors: Zheng Liu, Chunqing Guo, Swadesh K. Das, Xiaofei Yu, Anjan K. Pradhan, Xia Li, Yanxia Ning, Shixian Chen, Wenjie Liu, Jolene J. Windle, Harry D. Bear, Masoud H. Manjili, Paul B. Fisher, Xiang-Yang Wang

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362391588

Cites:

Cited by:

Related to: 10